MedTrace Logo

Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

NCT06976073 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2025-05-16

No results posted yet for this study

Summary

The goal of this clinical investigation is to explore a non-invasive technology for measuring the microcirculatory structure, composition and function in patients from a primary care population.

The main aims are:

1. To evaluate the robustness of the technology for assessment of the molecular composition and structure of the skin tissue and microcirculatory function, on a prospective primary care population.
2. To evaluate the device and method on its capability to detect deficiencies in circulation, compared with existing reference systems with similar characteristics for patients with known cardiovascular disease risk and/or diabetes.

Conditions

  • Diabetes Mellitus, Type 2
  • Diabetic Foot
  • Peripheral Arterial Disease
  • Skin Cancer
  • Cardiovascular Disease Risk

Sponsors & Collaborators

  • HJN Sverige AB/Neko Health

    lead INDUSTRY

Principal Investigators

  • Samuel Rodgers, MD · HJN Sverige AB/Neko Health AB

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2026-01-01
Completion
2026-01-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06976073 on ClinicalTrials.gov